Doug Jamison is Chairman and Chief Executive Officer and a Managing Director of Harris & Harris Group, Inc., a publicly traded venture capital company listed on the Nasdaq Global Market (NASDAQ: TINY). Harris & Harris Group focuses solely in making initial investments in “tiny” technologies, which it defines as nanotechnology and microsystems.
He has previously held the positions of President, Chief Operating Officer and Chief Financial Officer of Harris & Harris Group, Inc. He is also currently Chairman and Chief Executive Officer of H&H Ventures Management, Inc., a wholly owned subsidiary of Harris & Harris Group. He is a member of the Board of Directors of HzO, Inc., and a Board observer in ABS Materials, Inc., Produced Water Absorbents, Inc., and Metabolon, Inc., privately held nanotechnology-enabled portfolio companies of Harris & Harris Group. He was responsible for Harris & Harris Group's investment in Solazyme, Inc. (Nasdaq: SZYM) prior to it going public in May 2011.
He was also a member of the Board of Directors of Innovalight, Inc., prior to its acquisition by E.I. du Pont de Nemours and Company. He is Co-Editor-in-Chief of "Nanotechnology Law & Business." He is a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board, and a member of the Advisory Board, Massachusetts Technology Collaborative Nanotechnology Venture Forum. Prior to joining Harris & Harris Group, he was a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property in physics, chemistry and the engineering sciences.
He is a graduate of Dartmouth College (B.A., 1992) and the University of Utah (M.S., 1999).